Contacts

Investor Relations Group Headquarters

F. Hoffmann-La Roche Ltd.
Investor Relations
CH-4070 Basel
Switzerland
Email IR Team

For all general enquiries please call the Roche switchboard on
+41 61 688 1111

For IR requests use
+41 61 688 8880
+41 61 691 0014

Your contact persons

Karl Mahler
Head of Investor Relations
+41 61 687 8503
Sabine Borngräber
IR Officer
+41 61 688 8027
Bruno Eschli
IR Officer
+41 61 687 5284
Birgit Masjost
IR Officer
+41 61 688 4814
Gerard Tobin
IR Officer
+ 41 61 68 72942
Jon Kaspar Bayard
Junior IR Officer
+41 61 68 83894
Beatrice Hau
Coordination
+41 61 688 9274
Melanie Wolf
Coordination
+41 61 687 8259
Eva Losert
Coordination
+41 61 688 0284

Investor Relations North America

Roche Holdings, Inc.
Genentech, Inc.
Investor Relations North America
1 DNA Way
South San Francisco, CA 94080
USA
Email IR Team

For all general enquiries please call the Genentech switchboard on
+1 650 225 1000

For IR requests use
+1 650 225 5566
+1 650 225 8326

Your contact persons

Loren Kalm
Investor Relations Officer
+1 650-225-3217
Lisa Tuomi
Investor Relations Officer
+1 650-467-8737

Adverse event reporting

Please note that the provided investor contacts on this site are not to be used to report adverse events or to ask any questions regarding medical products.

Reporting side-effects related to our products should be sent to your Roche local safety contact. For country-specific contact details please visit: https://www.roche.com/products/local_safety_reporting.htm?acc1=tab1

Patients are being asked to primarily contact their personal physician.